what is a glp 1 agonist medication Diabetes Patients Also Struggle to Access GLP-1 Agonists List of approved and pending
Description
Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality
GoodRx reports that while satisfaction with GLP-1s for weight loss is high, costs and access issues significantly impact patient experiences.
Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020
Should a drug with the FDAs most serious warning be this easy to access for 1.4 billion people
